New research: A protein-based vaccine that mimics shape of coronavirus

The findings on their protein-based vaccine have been published in ACS Central Science.

An illustration of the novel coronavirus

Researchers have immunised mice with nanoparticles that mimic SARS-CoV-2 by displaying multiple copies of the receptor binding domain (RBD) antigen.

The findings on their protein-based vaccine have been published in ACS Central Science.

The team made nanoparticles similar in size to SARS-CoV-2 and decorated them with many RBDs. They injected them into mice, along with separate nanoparticles containing an adjuvant, in two doses three weeks apart.

Story continues below this ad

For comparison, they immunised another group of mice with polymersomes that encapsulated the RBD, along with the nanoparticles containing the adjuvant.

Although both groups of mice produced high levels of RBD-specific antibodies, only the surface-decorated nanoparticles generated neutralising antibodies that prevented SARS-CoV-2 infection in cells.

Source: American Chemical Society

Air India safety violations, Air India show cause notices, Air India Boeing 787 crash, Air India London Gatwick crash, DGCA Air India inspections,

‘Unfortunate’: SC slams reports suggesting ‘pilot error’ led to Air India crash

Legal4 hr ago

The Supreme Court Monday issued notice on a plea seeking an independent and expeditious investigation into the June 12, 2025, crash of an Air India Boeing Dreamliner in Ahmedabad, which killed 260 people. The bench also termed as “unfortunate” media reports which indicated that “pilot error” was to blame for the crash, purportedly quoting some preliminary findings by the AAIB.

View all shorts

More Explained

Explained PM Modi says 'GST savings festival' begins: with lower prices, how household budgets are set for boost